Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan

This study investigated the “real-world” use of ranibizumab for neovascular age-related macular degeneration (nAMD) in Taiwan and assessed the visual outcome. We reviewed the medical records at National Cheng Kung University Hospital, Taiwan, during 2012–2014 for 264 consecutive eyes of 229 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yi-Sheng, Lee, Wan-Ju, Lim, Chen-Chee, Wang, Shih-Hao, Hsu, Sheng-Min, Chen, Yi-Chian, Cheng, Chia-Yi, Teng, Yu-Ti, Huang, Yi-Hsun, Lai, Chun-Chieh, Tseng, Sung-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945845/
https://www.ncbi.nlm.nih.gov/pubmed/29748599
http://dx.doi.org/10.1038/s41598-018-25864-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945845/
https://www.ncbi.nlm.nih.gov/pubmed/29748599
http://dx.doi.org/10.1038/s41598-018-25864-0

Ejemplares similares